ALKERMES | Salg Og Administrasjonskostnader



Selling And Administration Expenses Endring Dato
AbbVie USD 3.86B 306M 2024-12
Acadia Pharmaceuticals USD 130.08M 3.21M 2024-12
ALKERMES USD 146.99M 3.39M 2024-12
Amgen USD 1.88B 253M 2024-12
Biogen USD 677.3M 99.6M 2024-12
BioMarin Pharmaceutical USD 256.77M 46.81M 2024-12
Bristol-Myers Squibb USD 2.1B 129M 2024-12
Eli Lilly USD 2.42B 324.7M 2024-12
Gilead Sciences USD 1.86B 451M 2024-12
Ionis Pharmaceuticals USD 88.08M 26.44M 2024-12
J&J USD 6.45B 975M 2024-12
Malin Corporation EUR 700K 1.6M 2024-06
Merck USD 2.85B 148M 2024-12
Neurocrine Biosciences USD 287.8M 53.5M 2024-12
Otsuka Holdings JPY 263.29B 21.96B 2024-12
Pfizer USD 4.27B 1.06B 2024-12
Regeneron Pharmaceuticals USD 792.2M 77.8M 2024-12
Vertex Pharmaceuticals USD 377.6M 5.8M 2024-12



ALKERMES Salg Og Administrasjonskostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.